IBDEI1I4 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24285,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,24285,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,24285,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,24286,0)
 ;;=E11.43^^82^1051^2
 ;;^UTILITY(U,$J,358.3,24286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24286,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,24286,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,24286,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,24287,0)
 ;;=E11.44^^82^1051^1
 ;;^UTILITY(U,$J,358.3,24287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24287,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,24287,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,24287,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,24288,0)
 ;;=E11.49^^82^1051^7
 ;;^UTILITY(U,$J,358.3,24288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24288,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,24288,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,24288,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,24289,0)
 ;;=E11.59^^82^1051^24
 ;;^UTILITY(U,$J,358.3,24289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24289,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,24289,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,24289,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,24290,0)
 ;;=E11.610^^82^1051^8
 ;;^UTILITY(U,$J,358.3,24290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24290,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,24290,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,24290,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,24291,0)
 ;;=E11.618^^82^1051^25
 ;;^UTILITY(U,$J,358.3,24291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24291,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,24291,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,24291,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,24292,0)
 ;;=E11.621^^82^1051^15
 ;;^UTILITY(U,$J,358.3,24292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24292,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,24292,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,24292,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,24293,0)
 ;;=E11.622^^82^1051^30
 ;;^UTILITY(U,$J,358.3,24293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24293,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,24293,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,24293,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,24294,0)
 ;;=E11.628^^82^1051^29
 ;;^UTILITY(U,$J,358.3,24294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24294,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,24294,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,24294,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,24295,0)
 ;;=E11.630^^82^1051^32
 ;;^UTILITY(U,$J,358.3,24295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24295,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,24295,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,24295,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,24296,0)
 ;;=E11.638^^82^1051^28
 ;;^UTILITY(U,$J,358.3,24296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24296,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,24296,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,24296,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,24297,0)
 ;;=E11.641^^82^1051^19
 ;;^UTILITY(U,$J,358.3,24297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24297,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
